References
- Brakman P., Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest 1963; 15: 603
- Jacobsen C. D. The antiplasmin activity of human plasma and serum and its dependence on ions. Arch. intern. Med 1964; 16: 383
- Lauritsen O. S. Some observations on the caseinotytic properties of a purified, activator-free, porcine plasmin preparation. Arch. intern. Med 1966a; 18
- Andersen H. The influence of time upon the inhibition of plasmin by normal, human serum. Arch. intern. Med 1966b; 18
- Müllertz S. Mechanism of activation and effect of plasmin in blood. Acta physiol. scand 1956; 38(Suppl. 130)44
- Nilsson I. M., Krook H., Sternby N. H., Söderberg E., Söderström N. Severe thrombotic disease in a young man with bone marrow and sceletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta med. scand 1961; 169: 323
- Norman P. S. Studies on the plasmin system II Inhibition of plasmin by serum or plasma. J. exp. Med 1958; 108: 53
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest 1962; 14: 138
- Rybak M. A study of the plasmin-inhibitor reaction. Physiol. bohemoslov 1962; 11: 470
- Taylor F. B., jr., Allen L. W., Bickford A. F., jr. Fractionation and characterisation of an inhibitor of plasmin found in normal plasma. Arch. Biochem 1964; 104: 277